Companies: 10,795·Total market cap: $144.5T
CureVac N.V.

CureVac N.V.

CVACNASDAQHealthcare
$4.66
+$0.00(+0.00%)
Market Cap$1.0B
P/E Ratio—
52W High$5.72
52W Low$2.475
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

CureVac N.V. (CVAC) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001809122 · CVAC · NASDAQ · as of Jun 8, 2026

Filing snapshot

274
Total Filings
15-12G
Latest Form
2026-01-16
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001809122 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2025-04-11
Fiscal Year End
Apr 11, 2025
Accession No.
0001410578-25-000692
Primary Document
cvac-20241231x20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001809122 · Accession 0001410578-25-000692

Latest Key Filings

6-KQuarterly Report
6-K
2026-01-06
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2026-01-16
View
S-8 POSS-8 POS
S-8 POS
2026-01-07
View
25-NSE25-NSE
25-NSE
2026-01-06
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-01-06
View
SC TO-T/ASC TO-T/A
SC TO-T/A
2025-12-18
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2025-12-18
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-12-12
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-12-12
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-12-12
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-12-05
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2025-12-05
View
SC TO-T/ASC TO-T/A
SC TO-T/A
2025-12-03
View
425425
425
2025-12-03
View
SC TO-T/ASC TO-T/A
SC TO-T/A
2025-11-26
View
425425
425
2025-11-26
View
Showing 1–15 of 262 filingsForm 4 / 144 hidden· 274 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001809122  |  Exchange: NASDAQ · Healthcare

CureVac N.V. (NASDAQ: CVAC) has submitted 274 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001809122, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is CureVac N.V.'s most comprehensive regulatory disclosure. The most recent CureVac N.V. 10-K was filed on 2025-04-11 for fiscal year ending 2025. Historical CVAC 10-K annual reports are available from 2020 through 2025.

Investors researching CureVac N.V. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
RLAY SEC Filings →ELVN SEC Filings →NVAX SEC Filings →SNDX SEC Filings →IMTX SEC Filings →INBX SEC Filings →TRML SEC Filings →NKTR SEC Filings →
→ CVAC Financials→ CVAC Earnings→ CVAC Insider Trades

Frequently Asked Questions

CVAC SEC Filings · 8 questions

CureVac N.V. (CVAC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 274 filings and access original documents at no cost. CureVac N.V.'s CIK is 0001809122.

CVAC SEC filingsCureVac N.V. SEC documentsfind CVAC 10-K